Chronic Lymphocytic Leukemia
📧 Sign up to get email alerts when something new happens for Chronic Lymphocytic Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-06-16Clinical Trial Update: A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma [Phase 1]
This Phase 1 trial investigates escalating doses of polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic ly…
-
CLINICAL_TRIALS trial_result · 2017-06-14Clinical Trial Update: A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia
This study evaluated Rituximab in combination with chemotherapy for CD20-positive B-cell chronic lymphocytic leukemia and has completed with…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Rapid Infusion of Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 clinical trial update evaluating rapid infusion of ofatumumab in patients with previously treated chronic lymphocytic leukemia; resu…
-
CLINICAL_TRIALS trial_result · 2017-06-06Clinical Trial Update: Study Evaluating AMD3100 for Transplantation of Sibling Donor Stem Cells in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 study evaluating plerixafor (AMD3100) as a stem cell mobilizer for transplantation from a sibling donor in various hematologic mal…
-
CLINICAL_TRIALS trial_result · 2017-06-02Clinical Trial Update: Flavopiridol in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia or Lymphocytic Lymphoma [Phase 1, Phase 2]
Clinical trial update reports completed Phase 1 and Phase 2 results for flavopiridol in previously treated chronic lymphocytic leukemia and …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) [Phase 2]
A Phase 2 open-label study evaluating MEDI-551 in adults with relapsed or refractory chronic lymphocytic leukemia; the trial has completed a…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating a multi-modality approach combining Yttrium-90 ibritumomab tiuxetan, fludarabine, radiation therapy, and d…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell Lymphoma [Phase 2]
Phase 2 trial evaluating rituximab in patients undergoing donor peripheral blood stem cell transplantation for relapsed or refractory B-cell…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: NOX-A12 in Combination With Bendamustine and Rituximab in Relapsed Chronic Lymphocytic Leukemia (CLL) [Phase 2]
This clinical trial update reports completion of a Phase 2 study evaluating NOX-A12 in combination with bendamustine and rituximab for relap…
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: A Study of Idelalisib and Rituximab in Elderly Patients With Untreated CLL or SLL [Phase 2]
Phase 2 trial of idelalisib plus rituximab in elderly patients with untreated CLL or SLL; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies [Phase 2]
Phase 2 trial update evaluating Penostatin, Rituximab, Ontak, and allogeneic NK cells in refractory lymphoid malignancies has completed with…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age [Phase 2]
Phase 2 clinical trial evaluating lenalidomide in older patients with chronic lymphocytic leukemia. The study results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-05-17Clinical Trial Update: Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy
This clinical trial update reports on biomarker analyses using DNA samples from patients with chronic lymphocytic leukemia who had prior flu…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Safety and Tolerability of HSC835 in Patients With Hematological Malignancies [Phase 1, Phase 2]
Phase 1/2 trial assessing safety and tolerability of HSC835 in patients with various hematologic malignancies completed with results posted …
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells [Phase 1, Phase 2]
A terminated Phase 1/2 clinical trial evaluated haploidentical allogeneic transplantation with post-transplant regulatory T-cell infusion in…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Efficacy and Safety of Idelalisib in Combination With Rituximab in Patients With Previously Untreated Chronic Lymphocytic Leukemia With 17p Deletion [Phase 2]
Phase 2 trial assessing idelalisib plus rituximab in previously untreated CLL with 17p deletion; study terminated with posted results in 201…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation [Phase 1]
A Phase 1 pilot study evaluating disruption of the lymphoid tumor microenvironment prior to autologous stem cell transplantation was termina…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies [Phase 2, Phase 3]
A phase 2/3 trial evaluating non-myeloablative allogeneic HSCT from HLA-matched related or unrelated donors in low-grade B-cell malignancies…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia [Phase 2]
An open-label Phase 2 trial evaluating lenalidomide in combination with oral dexamethasone for previously untreated, symptomatic chronic lym…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma [Phase 2]
Phase 2 trial evaluating donor stem cell transplantation for high-risk chronic lymphocytic leukemia or small lymphocytic lymphoma has comple…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: A Phase I, Multicenter, Dose Escalation Study of CAT-8015 in Participants With Chronic Leukemia [Phase 1]
A Phase I dose-escalation study of CAT-8015 (moxetumomab pasudotox) in participants with chronic leukemia; the trial was terminated and resu…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Study of Immune Responses to Influenza Vaccination With or Without Imiquimod Application in Untreated CLL Patients [Phase 2]
Phase 2 trial assessing immune responses to influenza vaccination in untreated Chronic Lymphocytic Leukemia patients with or without Imiquim…